Stability of extemporaneously prepared oxandrolone oral suspensions

Johnson, Cary E.; Cober, Mary Petrea; Hawkins, Katherine A.; Julian, Justin D.
March 2011
American Journal of Health-System Pharmacy;3/15/2011, Vol. 68 Issue 6, p519
Academic Journal
Purpose. The stability of extemporaneously prepared oxandrolone oral suspensions was studied. Methods. Oxandrolone oral suspension (1 mg/mL) was prepared using oxandrolone tablets, Ora-Plus, and either Ora-Sweet or Ora-Sweet SF. Three identical samples of each formulation were prepared and stored in 2-oz amber plastic bottles with child-resistant caps at room temperature (23-25 °C). After thorough but gentle shaking by hand to prevent foaming, a 1-mL sample was withdrawn from each of the six bottles, diluted with mobile phase to an expected concentration of 200 µg/mL, and assayed in duplicate by injecting 5 µL into the high-performance liquid chromatography system immediately after preparation and at 7, 14, 35, 60, and 90 days. The samples were examined for any change in color or pH on each day of analysis. The stability of the suspensions was determined by calculating the percentage of the initial oxandrolone concentration remaining on each test day. Stability was defined as the retention of at least 90% of the initial oxandrolone concentration. Results. At least 98% of the original oxandrolone concentration remained in both formulations at the end of the 90-day study period. There was no appreciable change in odor, taste, color, or pH. Both suspensions remained white in color and sweet with no aftertaste throughout the study period. The oxandrolone was easily resuspended with gentle shaking. Conclusion. Extemporaneously prepared suspensions of oxandrolone 1 mg/mL in 1:1 mixtures of Ora-Plus and either Ora-Sweet or Ora-Sweet SF were stable for at least 90 days when stored in 2-oz amber plastic bottles at room temperature.


Related Articles

  • Stability of extemporaneously prepared glycopyrrolate oral suspensions. Cober, Mary Petrea; Johnson, Cary E.; Sudekum, David; Penprase, Kimberly // American Journal of Health-System Pharmacy;5/1/2011, Vol. 68 Issue 9, p843 

    Purpose. The stability of extemporaneously prepared glycopyrrolate 0.5-mg/mL suspensions was evaluated. Methods. An oral suspension of glycopyrrolate 0.5 mg/mL was prepared by thoroughly grinding 30 1-mg tablets of glycopyrrolate in a glass mortar. Thirty milliliters of Ora-Plus and 30 mL of...

  • DEVELOPMENT AND EVALUATION OF ORAL RECONSTITUTABLE SYSTEMS OF CEPHALEXIN. Shanbhag, Pradnya Palekar; Bhalerao, S. S. // International Journal of PharmTech Research;Jan-Mar2010, Vol. 2 Issue 1, p502 

    Cephalexin, a cephalosporin antibiotic was chosen as the model drug candidate to obtain a dosage form with improved stability, palatability and attractive paediatric elegance, cost effective and with ease of administration. The present work was carried out to design and develop oral...

  • Compatibility of Vancomycin and Oxacillin During Simulated Y-Site Delivery. Teibel, Hilary M.; Knoderer, Chad A.; Nichols, Kristen R. // Hospital Pharmacy;Sep2015, Vol. 50 Issue 8, p710 

    Background: Vancomycin and oxacillin may be used together as empiric coverage in patients with proven or suspected Staphylococcus aureus infections. Though vancomycin hydrochloride 20 mg/mL and oxacillin sodium 160 mg/mL are reported to be compatible via Y-site delivery, Y-site compatibility of...

  • Homeopathic Potentization Based on Nanoscale Domains. Czerlinski, George; Ypma, Tjalling // Journal of Alternative & Complementary Medicine;Dec2011, Vol. 17 Issue 12, p1165 

    Objectives: The objectives of this study were to present a simple descriptive and quantitative model of how high potencies in homeopathy arise. Design: The model begins with the mechanochemical production of hydrogen and hydroxyl radicals from water and the electronic stabilization of the...

  • Stability of an extemporaneously prepared tadalafil suspension. PETTIT, REBECCA S.; JOHNSON, CARY E.; CARUTHERS, REGINE L. // American Journal of Health-System Pharmacy;4/1/2012, Vol. 69 Issue 7, p592 

    Purpose. The stability of an extemporaneously prepared tadalafil oral suspension was studied. Methods. An oral suspension of tadalafil 5 mg/mL was prepared by thoroughly grinding 15 20-mg tadalafil tablets in a glass mortar. Thirty milliliters of Ora-Plus and 30 mL of Ora-Sweet were mixed and...

  • How to pick the best Pill for your patient. Shah, Rupal // GP: General Practitioner;6/9/2003, p74 

    The article presents key factors that help women to choose a contraceptive. Consultations on contraception focus on finding the right method for each woman. Yasmin pill contains the progesterone drospirenone, an analogue of spironolactone, with oestradiol 30µg. It is aimed at women who have...

  • What can happen when suspensions are not shaken? Ellis, David P. // Journal of Pharmacy Practice & Research;Mar2011, Vol. 41 Issue 1, p79 

    A letter to the editor is presented which is concerned withe importance of shaking liquid medications.

  • FORMULATION AND EVALUATION OF HYDROTROPIC SOLUBLIZATION BASED SUSPENSIONS OF GRISEOFULVIN. Anilreddy, B. // International Journal of Pharma & Bio Sciences;Oct-Dec2010, Vol. 1 Issue 4, pP650 

    Hydrotropes increases the solubility of organics in water. Objective of present investigation was to enhance the solubility of griseofulvin using the technique of hydrotropic solubilization technique and convert them into suitable oral liquid dosage form (suspension) useful for enhancement of...

  • Stability of zonisamide in extemporaneously compounded oral suspensions. Abobo, Cyril V.; Bo Wei; Dong Liang // American Journal of Health-System Pharmacy;6/15/2009, Vol. 66 Issue 12, p1105 

    Purpose. The stability of extemporaneously prepared oral suspensions of zonisamide at room temperature and under refrigeration is evaluated. Methods. Simple-syrup and methylcellulose (0.5%) suspensions of zonisamide (10 mg/mL) were prepared using commercially available 100-mg capsules of...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics